Eucrates Biomedical Acquisition Corp. Quarterly Return On Assets in % from Q2 2021 to Q4 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Eucrates Biomedical Acquisition Corp. quarterly/annual Return On Assets history and growth rate from Q2 2021 to Q4 2022.
  • Eucrates Biomedical Acquisition Corp. Return On Assets for the quarter ending December 31, 2022 was 2.95 %, a 18.7% decline year-over-year.
  • Eucrates Biomedical Acquisition Corp. annual Return On Assets for 2022 was 2.95 %, a 18.7% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 2.95 -0.68 -18.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 2.4 +3.68 Jul 1, 2022 Sep 30, 2022
Q2 2022 2.81 +5.71 Apr 1, 2022 Jun 30, 2022
Q1 2022 3 Jan 1, 2022 Mar 31, 2022
Q4 2021 3.63 Oct 1, 2021 Dec 31, 2021
Q3 2021 -1.28 Jul 1, 2021 Sep 30, 2021
Q2 2021 -2.9 Apr 1, 2021 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.